roflumilast

Key facts

INN

roflumilast

Brand

ROFLUMILAST

Route

TOPICAL

Formulation

FOAM

Originator

Arcutis Biotherapeutics

Related patents

patent

US 12336983

Inhibition of crystal growth of roflumilast

Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12329751

Topical roflumilast formulation having antifungal properties

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12310956

Topical roflumilast formulation having improved delivery and plasma half-life

Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12257242

Inhibition of crystal growth of roflumilast

Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12220409

Roflumilast formulations with an improved pharmacokinetic profile

Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12144802

Pharmaceutical compositions of roflumilast and solvents capable of dissolving hi

Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12042558

Method and formulation for improving roflumilast skin penetration lag time

Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12016848

Roflumilast formulations with an improved pharmacokinetic profile

Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is roflumilast?

roflumilast (ROFLUMILAST), is a pharmaceutical active ingredient, associated with Arcutis Biotherapeutics, with approved status in the US.

What is the brand name for roflumilast?

ROFLUMILAST is a marketed brand name for roflumilast. Check FDA Drugs@FDA for the current US label holder.